Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies - Nature Communications
Modeling and Addressing On-Target/Off-Tumor Toxicity of Claudin 18.2 Targeted Immunotherapies Claudin 18.2 (CLDN18.2) has become a promising target for upper gastrointestinal (GI) cancer …